JENNIFER SMITH: Open Payments
NPI 1962707042 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 16 payments from 11 companies in 2025. Trend: 2023 $1,344 · 2024 $439 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Lilly USA, LLC | 2 | $46 |
| Dexcom, Inc. | 2 | $38 |
| Boston Scientific Corporation | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $27 |
| Amgen Inc. | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: QULIPTA, CAPLYTA, Dexcom G6 Transmitter, UBRELVY, WaveWriter Alpha Prime 16, REXULTI, AVEIR, JARDIANCE.
Industry payments across FL — which companies pay providers there.
